Mark Zuckerberg and wife Dr. Priscilla Chan recently announced a $3 billion initiative geared towards curing most of the world’s diseases called the Biohub. Through the Chan Zuckerberg Initiative, the couple managed to draw support from other billionaires and ordinary people alike in terms of funding and cooperation. Recently, the Facebook founder released a post detailing how a meeting with top scientists gave him hope that most, if not all of the world’s diseases will be gone by 2115.
The scientists in question are at the top of their fields with regards to dealing with illnesses and they come from multiple origins, including Stanford University and UC Berkeley. Heading the team is Dr. Cori Bargmann, who is a Rockefeller neuroscientist, Futurism reports.
Even with excellent brains behind the operation, the goal of eradicating even just a majority of the known diseases plaguing the world is a monumental undertaking. Much of the challenges has to do with research, which is a costly and time-consuming affair. The Biohub will take on a lot of the weight of the problems that usually prevent scientists from making swift progress, but even then, many would consider the 100-year timeline to be overly ambitious.
Zuckerberg and the team of scientists don’t seem to think so, however, and they point to the advancements that humanity has achieved in the last few decades in extending human lifespan. Global Futurist also notes how the initiative has already addressed one of the hurdles of getting to the point that they are aiming for; coordination.
There’s also the matter of the most recent innovations in medical and bioresearch to consider, which gives the lofty goals of a disease-free world a boost. There’s the new gene-editing tool called CRISPR, which is basically a starter kit for playing God. Then there’s the project called Cell Atlas, which aims to map all of the human body’s cells to address diseases that begin at the cellular level.


CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Huawei Chip Breakthrough Sparks Rally in Chinese Semiconductor Stocks
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements
SpaceX Starship V3 Test Flight Boosts IPO Momentum Ahead of Historic Market Debut
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs
Salesforce Q1 FY2027 Earnings Beat Expectations Despite Soft Q2 Revenue Outlook
SK Hynix Joins $1 Trillion Club as AI Chip Demand Fuels Stock Surge
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Why the future of marijuana legalization remains hazy despite high public support 



